MIST · Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

1111 Dr. Frederik-Philips Boulevard, Montreal, QC, H4M 2X6, Canada
Biotechnology
Healthcare

Market Cap

45.44M

52 Wk Range

$0.36 - $3.06

Previous Close

$0.52

Open

$0.51

Volume

8,803,345

Day Range

$0.36 - $0.52

Enterprise Value

-45.8M

Cash

145.4M

Avg Qtr Burn

-25.24M

Insider Ownership

0.83%

Institutional Own.

52.78%

Qtr Updated

Sep 30th 2026